Both in Pharmaceuticals
TherapeuticsMD vs CervoMed
Over the past year TXMD returned +55.6% and CRVO returned −77.8%; their daily moves had a correlation of 0.02.
TXMD +55.6% CRVO −77.8%Growth of $1, one year, split-adjusted
| Metric | TXMD | CRVO |
|---|---|---|
| Price | $1.82 | $1.56 |
| Market cap | $21.1M | $23.6M |
| Today | +2.25% | +0.65% |
| 1 month | −9.9% | −53.3% |
| 6 months | −10.3% | −59.3% |
| Year to date | +11.7% | −80.3% |
| 1 year | +58.3% | −77.8% |
| Revenue growth (YoY) | −8.7% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | 17.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.4× | 71.2× |
| Net cash | $9.2M | $24.9M |
| Dividend yield | — | — |
| Volatility (60d) | 34.2% | 88.5% |
| Short % of float | 0.2% | 12.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).